Wall Street's Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 7% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

Medical Properties Trust, Inc. MPW

• Dividend Yield: 8.54%
• Truist Securities analyst Michael Lewis maintained a Hold rating and cut the price target from $6 to $4 on Dec. 19, 2024. This analyst has an accuracy rate of 69%.
• RBC Capital analyst Michael Carroll downgraded the stock from Outperform to Sector Perform with a price target of $5 on May 14, 2024. This analyst has an accuracy rate of 61%.
• Recent News: On Nov.7, Medical Properties Trust reported worse-than-expected third-quarter financial results.
• Benzinga Pro's real-time newsfeed alerted to latest MPW news.

EPR Properties EPR

• Dividend Yield: 7.74%
• JP Morgan analyst Anthony Paolone maintained an Overweight rating and raised the price target from $48 to $51 on Sept. 9, 2024. This analyst has an accuracy rate of 64%.
• Truist Securities analyst Ki Bin Kim maintained a Hold rating and boosted the price target from $44 to $46 on Aug. 16, 2024. This analyst has an accuracy rate of 67%.
• Recent News: On Oct. 30, EPR Props posted better-than-expected quarterly results.
• Benzinga Pro's real-time newsfeed alerted to latest EPR news.

Omega Healthcare Investors, Inc. OHI

• Dividend Yield: 7.39%
• RBC Capital analyst Michael Carroll maintained a Sector Perform rating and raised the price target from $39 to $43 on Nov. 11, 2024. This analyst has an accuracy rate of 61%.
• Wells Fargo analyst Connor Siversky assumed an Overweight rating and increased the price target from $40 to $43 on Oct. 1, 2024. This analyst has an accuracy rate of 63%.
• Recent News: On Jan. 6, Omega Healthcare Investors named Matthew Gourmand as President.
• Benzinga Pro’s real-time newsfeed alerted to latest OHI news.

Read More:

• Top 2 Health Care Stocks That Are Ticking Portfolio Bombs